Statins Flashcards

1
Q

what is cholesterols role in the body?

A

-important in biosynthesis and cell membrane structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are used to transport cholesterol around the blood supply?

A

Low-density and high-density lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

where do LDLs carry cholesterol to?

A

cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where do HDLs carry cholesterol from and to?

A

from cells to the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what four things can happen if fatty plaques form in arteries due to cholesterol?

A
  1. artherosclerosis,
  2. clot formation,
  3. stroke and
  4. heart attack
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain how cholesterol is converted to bile acids and bile salts and what happens after??

A
  • 7α-hydroxylase catalyses initial rate-limiting step of the conversion.
  • then the bile acids are mostly reabsorbed through the enterohepatic circulation and returned back to the liver
  • this exerts a negative feedback control on 7α-hydroxylase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the process of cholesterol biosynthesis and state the number of steps between each reaction.

A
  1. Acetyl CoA (2 steps to 2)
  2. HMG CoA (using its reductase enzyme)
  3. Mevalonic acid (3 steps to 4)
  4. Isopentenyl Pyrophosphate (3 steps to 5)
  5. Farnesyl pyrophosphate (2 steps to 6)
  6. Squalene (2 steps to 7)
  7. Lanosterol (20 steps to 8)
  8. Cholesterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where is the primary control site for cholesterol biosynthesis?

A

HMG-CoA to Mevalonic Acid via the use of HMG CoA reductase enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

where does statin target to reduce cholesterol levels?

A

HMG-CoA reductase enzymes - the enzyme catalysing the rate limiting step in cholesterol synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the roles of Glutamic acid - 599 and Histidine - 866 in the reduction of HMG-CoA by HMG-CoA reductase?

A

act as acid catalysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the role of Lysine - 691 in the reduction of HMG-CoA by HMG-CoA reductase?

A

stabilises the negatively charged oxygen of Mevaldyl-CoA and the transition state leading to it. So it lowers activation energy for first step

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the role of aspartate residues - 767 in the reduction of HMG-CoA by HMG-CoA reductase?

A

stabilises Glu-599 and Lys 691

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does the HMG-CoA reductase inhibitor work - competitive or non-competitive?

A

by competitive inhibition of the reductase enzyme

it has a higher affinity for the enzyme than the substrate HMG-CoA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the general structure of Type 1 statins?

A
  • polar head
  • hydrophobic moiety
  • lots of asymmetric centres
  • with a decalin ring
    e. g. Lovastatin, Simvastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the benefit of making Lovastatin analogues with a longer interaction with the enzyme?

A
  • usually, an increase in the amount of HMG-CoA would reduce the effectiveness of the drug
  • but with the analogue, the enzyme and drug will be bound for longer therefore reducing effects of an increase in HMG-CoA concentrations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what structural modifications can be made to lovastatin to create a longer binding time with the enzyme?

A
  1. Make Ether side-chain analogues
  2. Homologation of the lactone ring
  3. converting lovastatin to
    mevalonate analogue (changing stereochemistry at the hydroxy-bearing-carbon in the lactone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the purpose of the homologation of the lactone ring?

A

to develop a lactone homologue that is compatible with the complex and has the same sensitive structural features of lovastatin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Explain how Lovastatin is converted to Mevalonate and the consequence of this change?

A
  • Mevalonate has a hydrody-bearing carbon just like HMG-CoA (the substrate). But lovastatin doesn’t.
  • however, the consequence of this change hasn’t been identified yet (so no results yet)
19
Q

what is the consequence of changing the ester analogue of lovastatin to an ether analogue?

A
  • showed that the absence of the carbonyl (C=O) had a detrimental effect on the inhibitory strength
  • concludes that side-chain ethers are weaker inhibitors than their corresponding ester analogues
20
Q

what are some downsides to Type 1 statins?

A
  1. Various side effects e.g. constipation, flatulence, dyspepsia, myopathy
  2. difficult to synthesise (main source is from mould cultures)- so it is semi-synthetic
  3. Large number of asymmetric centres
21
Q

what are type 2 statins made up of?

A

synthetic agents

22
Q

what is the general structure of type 2 statins?

A
  • Larger hydrophobic moiety
  • no asymmetric centres
  • structures with similar features
    e. g. fluvostatin, atorvastatin, rosuvastatin, cerivastatin
23
Q

which is the most potent type 2 statin and why?

A

rosuvastatin due to the sulphonamide group

24
Q

which is the most hydrophobic type 2 statin?

A

cerivastatin

25
Q

which is the least hydrophobic type 2 statin?

A

rosuvastatin

26
Q

where do statins with low hydrophobic character target?

A

liver cells

27
Q

which have more side effects, lower or higher hydrophobic statins? hence why type of statins are these?

A

higher hydrophobic statins (aka type 2 statins)

28
Q

which cells have transport proteins for statins?

A

Liver cells

29
Q

where does the majority of cholesterol synthesis take place?

A

in liver cells

30
Q

what is thought to be the main cause of side effects from the use of statins?

A

inhibition of HMGR in other cells such as muscle cells

31
Q

why was cerivastatin withdrawn from the market?

A

cause it caused rhabdomyolysis in patients (severe muscle toxicity which can be fatal)

32
Q

which part of the statin molecule mimics the HMGR substrate?

A

the polar head

with the hydrophobic part forming more binding interactions

33
Q

which type of statins can cross cell membranes easier?

A

Type 2 statins

34
Q

what intermediate are statins closer mimics of?

A

the first reaction intermediate (Mevaldyl CoA)

35
Q

why are statins also called transition-state analogues?

A

because they bear a resemblance to the transition state for the first stage of the reaction mechanism.

36
Q

what is the binding site of type 2 and type 1 statins?

A

type 2 = methylethyl substituent

type 1 = decalin ring

37
Q

why is rosuvastatin the most potent statin?

A
  • forms additional H-bonds
  • Sulfone oxygen forms a hydrogen bonding interaction with Ser-565
  • Sulfone group also interacts uniquely with Arg-568
38
Q

what helps rosuvastatin select the HMG-CoA Reductase?

A

the sulfone group

39
Q

what is part of the HMGRI is useful for inhibition?

A

3,5-dihydroxycarboxylate

40
Q

what effect does altering the two carbon distance between C5 and the ring system have?

A

diminishes or

fails to improve activity

41
Q

what is the decalin ring essential for in Ring A subclass statins?

A

The decalin ring is essential for anchoring the compound to the enzyme active site

42
Q

what effect does a methyl substitution at R2 position have in Ring A subclass statins?

A

Methyl substitution at the R2 position increases activity

43
Q

what effect does a b-Hydroxyl group have on the Ring A subclass statin?

A

b-Hydroxyl group substitution at the R1 position of the statin enhances hydrophilicity and
may provide some cellular specificity.

44
Q

what effect does substituting a aryl group, hydrocarbon chain, amide or sulphonamide into the Ring B subclass structure have on the statin?

A

enhances lipophilicity and inhibitory activity.